The Relationship Between Non-Transferrin-Bound Iron (NTBI), Labile Plasma Iron (LPI), and Iron Toxicity

Area of Science:

• Biochemistry
• Pathophysiology
• Cell Biology

Background:

• Plasma non-transferrin-bound iron (NTBI) exists in various forms, with labile plasma iron (LPI) being the redox-active and chelatable fraction.
• NTBI and LPI can enter cells through unregulated pathways, bypassing normal cellular iron control mechanisms.
• This unregulated iron uptake can lead to iron accumulation and toxicity in vital organs like the liver and heart.

Purpose of the Study:

• To elucidate the pathophysiological significance of NTBI and LPI in cellular iron overload.
• To explore the mechanisms of cellular entry for NTBI and LPI.
• To understand the differential contributions of NTBI and LPI to iron-mediated toxicity and oxidative stress.

Main Methods:

• Classification of NTBI subspecies based on composition, reactivity, and chelation susceptibility.
• Investigation of cellular entry mechanisms, including divalent metal transporters and passive diffusion.
• Analysis of factors influencing LPI concentration, such as iron overload extent and serum antioxidant capacity.

Main Results:

• NTBI and LPI facilitate unregulated cellular iron uptake, leading to potential iron overload and toxicity.
• Both NTBI and LPI contribute to oxidative stress through free-radical-generating reactions.
• LPI concentration is influenced by iron overload severity, residual iron-binding capacity, and serum antioxidant levels.

Conclusions:

• NTBI and LPI are key contributors to iron-mediated toxicity, with distinct roles based on their reactivity and availability.
• Understanding the dynamics of NTBI and LPI is crucial for comprehending iron overload pathologies.
• The interplay between iron overload conditions and individual serum characteristics modulates the pathogenic potential of LPI.